Updated Jul 16, 2026
Reed Joshua has filed 2 SEC Form 4 filings across 1 company in the last 90 days — selling. Lifetime open-market sales: $164K.
Joshua Reed is the Senior Vice President and Chief Financial Officer at Alkermes plc, a biotechnology company focused on developing pharmaceutical products for unmet medical needs. He has been involved in the financial management of the company, contributing to its strategic initiatives.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | SRRK | Scholar Rock Holding Corp | S — Open-market sale | 948 | $54.28 | $51K |
| 2026-07-06 | SRRK | Scholar Rock Holding Corp | S — Open-market sale | 2.1K | $53.50 | $113K |
| 2026-06-08 | SRRK | Scholar Rock Holding Corp | A — Grant or award | 6.8K | $0.00 |
Joshua Reed is the Senior Vice President and Chief Financial Officer at Alkermes plc, a biotechnology company focused on developing pharmaceutical products for unmet medical needs. He has been involved in the financial management of the company, contributing to its strategic initiatives.…
2 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($164K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Reed Joshua profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.